Rhodes Jason P
- SEC CIK
- 0001577014
In the past year, 8 open-market sale filings worth $129.1M and no purchases.
Current role at each company
- DYN Dyne Therapeutics, Inc.Directoras of Aug 17, 2026
- GBIO Generation Bio Co.Directoras of Feb 9, 2026
- REPL Replimune Group, Inc.Directoras of Apr 5, 2022
- IRON Disc Medicine, Inc.Director, 10% Owneras of Oct 6, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $129.1M
- 8 filings
- Net
- −$129.1M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Rhodes Jason P as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
DYN Dyne Therapeutics, Inc.
Director14 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 14, 2022 (view filing) | Dec 12 | 2 days | Rhodes Jason PDirector | PPurchase | +934.6K | $10.70 | +$10.0M | New position934.6K after | |
| Feb 20, 2024 (view filing) | Feb 15-20 | 5 days | Rhodes Jason PDirector | SSale | −510.2K | $23.26 | −$11.9M | −7.0%6.82M after | 5 lots10b5-1 |
| Feb 23, 2024 (view filing) | Feb 21-23 | 2 days | Rhodes Jason PDirector | SSale | −500.8K | $22.64 | −$11.3M | −35.2%920.8K after | 6 lots10b5-1 |
| Feb 28, 2024 (view filing) | Feb 26-28 | 2 days | Rhodes Jason PDirector | SSale | −807.8K | $24.30 | −$19.6M | −48.3%864.5K after | 18 lots10b5-1 |
| Mar 5, 2024 (view filing) | Mar 1 | 4 days | Rhodes Jason PDirector | SSale | −46.5K | $30.05 | −$1.40M | −5.2%847.4K after | 2 lots10b5-1 |
| Nov 18, 2024 (view filing) | Nov 14 | 4 days | Rhodes Jason PDirector | SSale | −782 | $33.10 | −$25.9K | −0.1%847.3K after | 4 lots |
| Apr 22, 2026 (view filing) | Apr 20-22 | 2 days | Rhodes Jason PDirector | SSale | −834.3K | $19.75 | −$16.5M | −39.4%1.29M after | 16 lots10b5-1 |
| Apr 27, 2026 (view filing) | Apr 23-27 | 4 days | Rhodes Jason PDirector | SSale | −384.5K | $18.47 | −$7.10M | −24.2%1.21M after | 12 lots10b5-1 |
| Apr 30, 2026 (view filing) | Apr 28 | 2 days | Rhodes Jason PDirector | SSale | −227.3K | $18.38 | −$4.18M | −16.4%1.16M after | 8 lots10b5-1 |
| May 6, 2026 (view filing) | May 4-6 | 2 days | Rhodes Jason PDirector | SSale | −106.7K | $18.14 | −$1.94M | −8.6%1.14M after | 12 lots10b5-1 |
GBIO Generation Bio Co.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 24, 2021 (view filing) | Sep 22-24 | 2 days | Rhodes Jason PDirector | SSale | −135.0K | $26.01 | −$3.51M | −99.4%757 after | 7 lots |
| Sep 29, 2021 (view filing) | Sep 27-29 | 2 days | Rhodes Jason PDirector | SSale | −81.1K | $25.40 | −$2.06M | −99.3%608 after | 6 lots |